Oncology
5,305 studies560 in 7 days2,549 in 30 days
Filters
Latest
5,305 studies
- Comparative Pharmacologic Characterization of Povorcitinib (INCB054707) as a Highly Selective Oral JAK1 Inhibitor
- Design of a biodegradable bone cement with enhanced mechanical and raloxifene-delivering properties
- USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization
- Characterization of a novel SERPINA1 variant carrying two missense mutations: molecular mechanisms and functional impact
- Tumor cell–intrinsic stress states drive sensitivity to CAR T cell therapy in pancreatic cancer
- A TERRA-NONO axis drives fibroblast reprogramming in cancer
- Development of a prediction model for occupational satisfaction among cancer patients following counseling in German psychosocial cancer counseling centers
- Characterization of plasma TNFRSF/TNFSF molecule profiles in HIV-associated disseminated Kaposi’s sarcoma over short- and long-term follow-up
- Transcriptome profile of s-SHIP expressing breast cancer cells identifies PIERCE1 as a novel drug-resistance gene
- A standardized clinical algorithm for patient selection in cellular therapy across nineteen solid and hematological malignancies: An algorithm development study
- Curcumin Artefacta – A Case Series of False Fluorescence in Ultraviolet Fluorescence Dermoscopy due to Topical Turmeric
- cAMP Analogs Induce p53-independent p21 Expression through Sp1-responsive Promoter Activation and p300-associated Epigenetic Regulation in PC-3 Human Prostate Cancer Cells.
- Clinical Procedure Exposures and Rare or Poorly Understood Cancers: A Case-control Study Using Electronic Health Records.
- Dietary Regulation of the Tumor Immune Microenvironment in Cancer Immunotherapy.
- Comparative in Silico Toxicological Assessment of 16 Selective COX-2 Inhibitors (Coxibs) Using Multi-Platform Predictive Models
- CTCF-associated chromatin changes between HOXD1 and HOXD8 contribute to TNBC progression
- Nuclear cathepsin L induces DNA damage by regulating DNA repair factors in ovarian cancer
- Immunobiology and Immune-Related Toxicities of Cancer Immunotherapy: Organ-Specific Immune-Related Adverse Events, Cytokine Release Syndrome, and Immune Effector Cell–Associated Neurotoxicity Syndrome
- Genomics-Guided Risk Stratification in Myeloma Precursor Conditions: Converging Frameworks From Whole-Genome Sequencing
- Analysis of the Correlation Between Peripheral Blood Lymphocyte Subsets and Pathological Complete Response Rate in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy
- Comprehensive benchmarking of somatic mutation detection by the SMaHT Network
- Supporting implementation of the national standards for cancer survivorship care: development of the cancer survivorship maturity model (CSMM)
- Cancer survivorship care among head and neck cancer patients living in rural and urban locations
- A novel oncolytic peptide synergizing with immunotherapy
- Solid Pseudopapillary Neoplasm of the Pancreatic Tail With Splenic Hilar Involvement: A Case Report.